Over the weekend, "Venom: The Last Dance" continued its reign at the top of the box office, bringing in $26.1 million in ticket sales. The Sony release, starring Tom Hardy, maintained its position despite facing a relatively quiet weekend at North American movie theaters leading up to the presidential election.
Other big studio holdovers like "The Wild Robot" and "Smile 2" also dominated the charts, while the Tom Hanks, Robin Wright, and Robert Zemeckis reunion film "Here" failed to make a significant impact with only $5 million in opening weekend sales.
"Venom 3" saw a modest 49% drop in its second weekend, making over $90 million domestically and crossing the $300 million threshold globally. Universal and Illumination's "The Wild Robot" continued to attract moviegoers six weeks in, earning $7.6 million and reaching over $121 million in North America and $269 million worldwide.
Despite its star-studded cast and unique concept, "Here" received poor reviews from critics and struggled to find an audience, coming in behind Focus Features' "Conclave" at the box office. The overall box office is still lagging behind 2023 by almost 12%, but upcoming holiday releases like "Gladiator II" and "Wicked" are expected to give the industry a boost.
In addition to the box office hits, Jesse Eisenberg's film "A Real Pain" had a successful limited release in New York and Los Angeles, earning an estimated $240,000 across four theaters. The well-reviewed film will expand nationwide in the coming weeks.
While some high-profile films like Clint Eastwood's "Juror #2" and Steve McQueen's "Blitz" did not report full grosses, the box office landscape remains diverse and dynamic. With major studios occasionally withholding numbers and streaming platforms like Netflix and Apple TV+ entering the mix, the movie industry continues to evolve in response to changing audience preferences and viewing habits.